$35M Series C Fuels Octave’s Commercial Momentum in Precision Neurology – Read the Release

Recent Announcements & Press

Octave Bioscience Announces $35M Series C Financing to Accelerate Commercial Momentum

Octave Bioscience to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Octave Strengthens Clinical Expertise in MS and Neurodegenerative Disease

Octave Note

MSMilan2023: Making a Mark at the World’s Largest MS Research Meeting

ACTRIMS Preview: Advancing the Science for Patients with MS

Barriers in MS Treatment Adherence

Media Library

living well

Bridging MS: Connecting You to Resources

living well

MRI in MS: From Pixels to Progress

living well

Multiple Sclerosis in Childhood